RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Bridging The Knowledge Gap On Digital Clinical Measures: A Technology Partner's Perspective On The 'The Playbook'
ActiGraph CEO, Jeremy Wyatt, shares his perspectives on The Playbook, the essential guide for remote patient monitoring in clinical research, clinical care and public health, compiled by the Digital Medicine Society (DiMe).
-
Securing Sponsor Reimbursement For CRIO Fees
Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.
-
Harnessing The Power Of eCOA Technology
Get an overview of this COA-focused panel at the C3 Summit in London where industry experts and leaders discussed challenges, opportunities, and strategies in clinical trial diversity, centricity, and outcome assessments.
-
How Flatiron Supported The Beat AML® Master Clinical Trial
Find out how the Leukemia and Lymphoma Society's partnership with Flatiron Health helped improve the Beat AML® Master Clinical Trial's data management and accelerate trial timelines.
-
Preparing Clinical Teams for 2026: AI, Automation & Integration
Clinical teams should prepare for 2026 by embracing AI, automation, and unified platforms to improve efficiency, data quality, and scalability in increasingly complex trials.
-
Supporting Early Phase Oncology Research With The Right Data Management System
Better understand how the evolving landscape drives innovation, why your data capture strategy needs the right technology foundation, and what to look for in a CDMS/EDC system for early-phase oncology.
-
How eCOA Improves Data Quality In Clinical Trials
eCOA solutions enhance data quality in clinical trials by preventing common issues in paper-based COA data, such as missing, ambiguous, or conflicting entries, and ensuring reliable data collection.
-
ICH E6(R3) Is Here: What Your Centralized Monitoring Strategy Needs
ICH E6(R3) turns best practices into regulatory mandates. Learn how to maintain sponsor accountability and implement proportionate centralized monitoring through a unified, auditable data layer.
-
Everest Group Life Sciences EDC Products PEAK Matrix® Assessment 2024
This Everest Group report examines Medidata’s Rave EDC and its impact on the clinical development value chain of life sciences.
-
Rare Disease Clinical Trials: Modern Design And Supply Chain
Gain insight from several contributing experts for overcoming unique obstacles in rare disease research and learn how to better develop strategies.
RECENT NEWSLETTERS
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working